Building the Future of
Cannabinoid Therapeutics℠
What We Do
Scopus BioPharma develops small molecule therapeutics leveraging world-class expertise in cannabinoid and cannabis research.
The endocannabinoid system is critical for maintaining overall human health by modulating key functions within the body.
Synthetically-Produced Cannabinoids
Cannabinoids are naturally produced in the body and can also be derived from the cannabis plant or be synthetically produced. The most well-known and researched plant-derived and synthetically-produced cannabinoids are cannabidiol, or CBD, and tetrahydrocannabinol, or THC. Our prescription drug candidates use synthetically-produced cannabinoids, ensuring the highest level of quality control and consistency.
World-Renowned Strategic Relationships
We are pursuing FDA approval for our proprietary drug candidates, distinguishing them from increasingly commoditized cannabinoid products and enabling a clear pathway unencumbered by legal challenges associated with non-FDA approved products. We are working with leading cannabinoid research scientists at preeminent academic and research institutions.
